Timothy P DiPeri

7PUBLICATIONS
41CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Social epidemiologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2025
Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

Kaushik Varadarajan, Christian X Cruz Pico, Kurt W Evans

|Nov 08, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.

Timothy P DiPeri, Kurt W Evans, Stephen Scott

|Feb 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

Timothy P DiPeri, Kurt W Evans, Bailiang Wang

|Sep 05, 2023
Socioeconomic disparities in patients with small bowel neuroendocrine tumors.

Timothy P DiPeri, Nicholas Manguso, Jun Gong

|Jun 20, 2023
Discordance of HER2 Expression and/or Amplification on Repeat Testing.

Timothy P DiPeri, Kathleen Kong, Kaushik Varadarajan

|Jun 06, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.

Timothy P DiPeri, Kurt W Evans, Maria Gabriela Raso

Pageof 2